Diagnosing and Managing Tardive Dyskinesia

Earn free CME/CE credit by learning about tardive dyskinesia (TD), a syndrome of involuntary movements associated with the long-term use of antipsychotic medications. 

Click here to read the supplement and earn free CME/CE credits by learning about TD and evidence based treatments. 

---

Educational Objectives

• Discuss the diagnosis, differential diagnosis and risk factors for TD
• Identify the prevalence of TD with antipsychotics
• Use the AIMS examination
• Review the evidence and non-evidence based treatments for TD
• Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
• Formulate appropriate treatment regimens considering
  the emergence of new FDA approved treatments for TD

Click here to read the supplement. 

 

Earn free CME/CE credit by learning about tardive dyskinesia (TD), a syndrome of involuntary movements associated with the long-term use of antipsychotic medications. 

Click here to read the supplement and earn free CME/CE credits by learning about TD and evidence based treatments. 

---

Educational Objectives

• Discuss the diagnosis, differential diagnosis and risk factors for TD
• Identify the prevalence of TD with antipsychotics
• Use the AIMS examination
• Review the evidence and non-evidence based treatments for TD
• Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
• Formulate appropriate treatment regimens considering
  the emergence of new FDA approved treatments for TD

Click here to read the supplement. 

 

Earn free CME/CE credit by learning about tardive dyskinesia (TD), a syndrome of involuntary movements associated with the long-term use of antipsychotic medications. 

Click here to read the supplement and earn free CME/CE credits by learning about TD and evidence based treatments. 

---

Educational Objectives

• Discuss the diagnosis, differential diagnosis and risk factors for TD
• Identify the prevalence of TD with antipsychotics
• Use the AIMS examination
• Review the evidence and non-evidence based treatments for TD
• Individualize treatment choices, giving consideration to efficacy, safety, long-term data, and unique patient characteristics
• Formulate appropriate treatment regimens considering
  the emergence of new FDA approved treatments for TD

Click here to read the supplement.